// App-Quantinova.ai

PATH-46 : COMPUTATIONAL HISTOPATHOLOGY INFORMED RAPID TARGETED NANOPORE SEQUENCING ENABLES AFFORDABLE NEXT DAY REPORTING OF COMPREHENSIVE MOLECULAR MARKERS FOR CNS TUMOUR DIAGNOSTICS

Researchers

Presenter

  • Areeba Patel

Principal Investigators

  • Alexander Jung

  • Zaira Seferbekova

  • Alexander Payne

  • Michael Ritter

  • Daniel Schrimpf

  • Damian Stichel

  • Stefan Hamelmann

  • Christina Blume

  • Philipp Euskirchen

  • Violaine Goidts

  • Martin Sill

  • Stefan Pfister

  • Matthew Loose

  • Wolfgang Wick

  • Andreas von Deimling

  • David T Jones

  • Matthias Schlesner

  • Moritz Gerstung

  • Felix Sahm

Medical Centers

  • Hopp Children’s Cancer Center (KiTZ), Heidelberg, Germany

  • Department of Neuropathology, University Hospital Heidelberg, and Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Baden-Wurttemberg, Germany

  • Brain Tumor Translational Targets, German Cancer Research Center (DKFZ), Heidelberg, Germany

  • Hopp Childrens Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Research Center (DKFZ), Heidelberg, Germany

  • European Molecular Biology Laboratory, European Bioinformatics Institute EMBL-EBI, Cambridge, United Kingdom

  • Division of Artificial Intelligence in Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany

  • Department of Neuropathology, Charité - Universitätsmedizin Berlin, Berlin, Germany

  • Biomedical Informatics, Data Mining and Data Analytics, Augsburg University, Augsburg, Germany

  • German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany, Heidelberg, Germany

  • Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Baden-Wurttemberg, Germany

  • DeepSeq, School of Life Sciences, University of Nottingham, Nottingham, United Kingdom

Locations

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved